Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Protalix BioTherapeutics Receives Israel Government Grant
As per the terms of the grant, up to $2.9m of the funds awarded are to be used for the advancement of the Protalix BioTherapeutics’ early-stage pipeline product
As per the terms of the grant, up to $2.9m of the funds awarded are to be used for the advancement of the Protalix BioTherapeutics’ early-stage pipeline product
Mission Pharmacal said that CitraNatal Harmony vitamins are specially formulated for women who require nutritional support prior to conception, throughout pregnancy and during the postnatal period. Mission Pharmacal
HepaLife Technologies is the developer of HepaMate, an extracorporeal cell-based bioartificial liver system designed to combine blood detoxification with liver cell therapy to provide whole liver function in
Biostar Pharma has posted a net income of $2.26m for the first quarter 2010, or $0.08 per diluted share, compared to $1.82m, or $0.08 per diluted share, for
Prescription Solutions and UnitedHealth Group company said that Atypical antipsychotics (AAs) are a group of newer-generation antipsychotic drugs that are indicated for the treatment of psychiatric conditions including
MitoSciences said that the tests, developed in collaboration with the University of Oregon, allow clinicians to identify adverse effects from drugs used to treat HIV/AIDS, hepatitis and other
NanoViricides said that under this agreement, Dr Rosenthal and coworkers are expected to evaluate the effectiveness of nanoviricides drug candidates against Herpes simplex virus 1 (HSV-1). Cell culture
Boston Scientific said that leads are insulated wires that carry heart signals to the implanted device and deliver energy from the device to the heart. Leads are inserted
SRI International said that to facilitate delivery of vitamin A to children who may not otherwise receive enough of it, its researchers are expected to plan to engineer
China Medicine has posted a net income of $1.79m for the first quarter of 2010, compared to $0.55m, for the prior year period. Income from operations was $1.24m,